TR200100752T2 - Entakapon ya da nitekaponun yanı sıra çapraz bağlı bir selüloz türevi kapsayan farmasötik kompozisyon - Google Patents

Entakapon ya da nitekaponun yanı sıra çapraz bağlı bir selüloz türevi kapsayan farmasötik kompozisyon

Info

Publication number
TR200100752T2
TR200100752T2 TR2001/00752T TR200100752T TR200100752T2 TR 200100752 T2 TR200100752 T2 TR 200100752T2 TR 2001/00752 T TR2001/00752 T TR 2001/00752T TR 200100752 T TR200100752 T TR 200100752T TR 200100752 T2 TR200100752 T2 TR 200100752T2
Authority
TR
Turkey
Prior art keywords
cellulose derivative
nitecapone
entacapone
cross
linked cellulose
Prior art date
Application number
TR2001/00752T
Other languages
English (en)
Inventor
Vahervuo Kari
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22542186&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200100752(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of TR200100752T2 publication Critical patent/TR200100752T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

Mevcut bulus; entakapon, nitekapon ya da onun farmasötik olarak uygun tuzu ve bir çapraz bagli selüloz türevini içeren bir oral yogun kompozisyon ile ilgilidir. Kompozisyon; çapraz bagli selüloz türevinin entakapon yada nitekaponun bir oral yogun kompozisyondan salinim hizini arttirdigi kesfine dayanir. Tercihen kompozisyondaki çapraz bagli selüloz türevi miktari agirligin en az %6'si, daha da tercihen yaklasik %8 ile %16'si arasinda, özellikle de yaklasik % 10 ile %14'ü arasindadir.
TR2001/00752T 1998-09-14 1999-09-13 Entakapon ya da nitekaponun yanı sıra çapraz bağlı bir selüloz türevi kapsayan farmasötik kompozisyon TR200100752T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/152,263 US6599530B2 (en) 1998-09-14 1998-09-14 Oral compacted composition comprising catechol derivatives

Publications (1)

Publication Number Publication Date
TR200100752T2 true TR200100752T2 (tr) 2001-10-22

Family

ID=22542186

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00752T TR200100752T2 (tr) 1998-09-14 1999-09-13 Entakapon ya da nitekaponun yanı sıra çapraz bağlı bir selüloz türevi kapsayan farmasötik kompozisyon

Country Status (39)

Country Link
US (1) US6599530B2 (tr)
EP (1) EP1112065B1 (tr)
JP (1) JP4619537B2 (tr)
KR (1) KR100732187B1 (tr)
CN (1) CN1151778C (tr)
AR (1) AR021806A1 (tr)
AT (1) ATE256454T1 (tr)
AU (1) AU746889B2 (tr)
BG (1) BG65041B1 (tr)
BR (1) BR9913681A (tr)
CA (1) CA2342634C (tr)
CO (1) CO5130008A1 (tr)
CZ (1) CZ293960B6 (tr)
DE (1) DE69913714T2 (tr)
DK (1) DK1112065T3 (tr)
EA (1) EA003282B1 (tr)
EE (1) EE04657B1 (tr)
ES (1) ES2213381T3 (tr)
GE (1) GEP20033062B (tr)
HK (1) HK1039750B (tr)
HR (1) HRP20010277B1 (tr)
HU (1) HU228910B1 (tr)
ID (1) ID29026A (tr)
IL (1) IL141681A0 (tr)
ME (1) ME00706B (tr)
MY (1) MY124394A (tr)
NO (1) NO331641B1 (tr)
NZ (1) NZ510583A (tr)
PE (1) PE20001060A1 (tr)
PL (1) PL193454B1 (tr)
PT (1) PT1112065E (tr)
RS (1) RS49723B (tr)
SI (1) SI1112065T1 (tr)
SK (1) SK284049B6 (tr)
TR (1) TR200100752T2 (tr)
TW (1) TWI222367B (tr)
UA (1) UA73925C2 (tr)
WO (1) WO2000015196A1 (tr)
ZA (1) ZA200102084B (tr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI109453B (fi) 1999-06-30 2002-08-15 Orion Yhtymae Oyj Farmaseuttinen koostumus
FI20000635A0 (fi) * 2000-03-17 2000-03-17 Orion Yhtymae Oyj COMT-inhibiittoreiden käyttö analgeettina
US7659253B2 (en) * 2002-02-22 2010-02-09 Shire Llc Abuse-resistant amphetamine prodrugs
JP2008519811A (ja) 2004-11-10 2008-06-12 オリオン コーポレーション 下肢静止不能症候群の治療
ATE444746T1 (de) * 2005-06-08 2009-10-15 Orion Corp Eine herstellungsmethode von entacapon- enthaltenden granulaten für orale dosierformen
AU2012216377C1 (en) * 2005-06-08 2013-10-10 Orion Corporation Oral dosage form
WO2007069274A2 (en) * 2005-11-09 2007-06-21 Torrent Pharmaceuticals Limited Pharmaceutical composition comprising a compound having a catechol moiety and an alkalising agent
WO2007095716A1 (en) * 2006-02-23 2007-08-30 Iomedix Sleep International Srl Compositions and methods for the induction and maintenance of quality sleep
GB2429645A (en) * 2006-03-10 2007-03-07 Sekhsaria Chemicals Ltd Solid pharmaceutical composition comprising a COMT inhibitor, a starch and a wetting agent
WO2007113371A1 (en) * 2006-03-31 2007-10-11 Iprbox Oy Pharmaceutical composition and preparation method thereof
CA2572004A1 (en) * 2006-12-08 2008-06-08 Bernard Charles Sherman Tablets comprising entacapone and crospovidone
EP1946756A1 (en) * 2007-01-17 2008-07-23 Revotar Biopharmaceuticals AG Use of entacapone in cosmetic, dermatological and pharmaceutical compositions
ATE534382T1 (de) * 2008-02-06 2011-12-15 Wockhardt Ltd Pharmazeutische zusammensetzungen von mit zuckeralkoholen zusammen mikronisiertem entacapon
AU2009211028B2 (en) * 2008-02-06 2013-12-05 Wockhardt Research Centre Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability
BRPI0916922A2 (pt) * 2008-08-22 2015-11-24 Wockhardt Research Center composição farmacêutica de liberação prolongada de entacapona ou sais da mesma
WO2011075912A1 (zh) * 2009-12-25 2011-06-30 台湾东洋药品工业股份有限公司 治疗帕金森氏症的医药组合物及其制备方法
WO2012147099A1 (en) 2011-04-25 2012-11-01 Suven Nishtaa Pharma Pvt. Ltd. Pharmaceutical compositions of levodopa, carbidopa and entacapone
EP2702991A4 (en) * 2011-04-26 2015-02-18 Innopharmax Inc COMPOSITION OF ENTACOPONE
WO2016083863A1 (en) 2014-11-28 2016-06-02 Bial - Portela & Ca, S.A. Medicaments for slowing parkinson's disease
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
EP3275433A1 (en) * 2016-07-29 2018-01-31 Som Innovation Biotech S.L. Sustained release composition comprising micronized tolcapone
CN106236720A (zh) * 2016-08-29 2016-12-21 海南通用康力制药有限公司 一种恩他卡朋的药物组合物及其制备方法
CN113274362A (zh) * 2021-03-31 2021-08-20 海南通用康力制药有限公司 恩他卡朋片的生产方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7084587A (en) * 1986-04-01 1987-10-20 Upjohn Company, The Methylprednisolone/sodium carboxymethyl starch tablet composition
YU213587A (en) * 1986-11-28 1989-06-30 Orion Yhtymae Oy Process for obtaining new pharmacologic active cateholic derivatives
US5283352A (en) * 1986-11-28 1994-02-01 Orion-Yhtyma Oy Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
US5489614A (en) * 1987-11-27 1996-02-06 Orion-Yhtyma Oy Catechol derivatives, their physiologically acceptable salts, esters and use
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
TW430561B (en) * 1995-12-20 2001-04-21 Gea Farmaceutisk Fabrik As Rapid release tablet composition comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tablet

Also Published As

Publication number Publication date
DE69913714D1 (de) 2004-01-29
ATE256454T1 (de) 2004-01-15
YU19301A (sh) 2003-02-28
HRP20010277A2 (en) 2002-06-30
CZ293960B6 (cs) 2004-08-18
NO331641B1 (no) 2012-02-13
MY124394A (en) 2006-06-30
BR9913681A (pt) 2001-06-05
EE200100147A (et) 2002-06-17
TWI222367B (en) 2004-10-21
GEP20033062B (en) 2003-09-25
HU228910B1 (en) 2013-06-28
ES2213381T3 (es) 2004-08-16
IL141681A0 (en) 2002-03-10
HUP0103454A2 (hu) 2002-01-28
HK1039750A1 (en) 2002-05-10
US6599530B2 (en) 2003-07-29
NZ510583A (en) 2002-09-27
KR100732187B1 (ko) 2007-06-27
AU746889B2 (en) 2002-05-02
DK1112065T3 (da) 2004-04-05
CO5130008A1 (es) 2002-02-27
AR021806A1 (es) 2002-08-07
CA2342634A1 (en) 2000-03-23
NO20011278L (no) 2001-03-13
PL346618A1 (en) 2002-02-25
EA003282B1 (ru) 2003-04-24
SI1112065T1 (en) 2004-04-30
KR20010075084A (ko) 2001-08-09
BG105436A (en) 2001-11-30
ME00706B (me) 2007-12-31
CN1319005A (zh) 2001-10-24
NO20011278D0 (no) 2001-03-13
DE69913714T2 (de) 2004-10-07
PE20001060A1 (es) 2000-10-20
ID29026A (id) 2001-07-26
HRP20010277B1 (hr) 2010-10-31
CN1151778C (zh) 2004-06-02
PL193454B1 (pl) 2007-02-28
SK284049B6 (sk) 2004-08-03
WO2000015196A1 (en) 2000-03-23
US20020132009A1 (en) 2002-09-19
JP2002524493A (ja) 2002-08-06
RS49723B (sr) 2007-12-31
CA2342634C (en) 2008-01-29
CZ2001792A3 (cs) 2001-08-15
AU5748299A (en) 2000-04-03
EA200100354A1 (ru) 2001-08-27
ZA200102084B (en) 2002-06-13
BG65041B1 (bg) 2007-01-31
UA73925C2 (uk) 2005-10-17
HK1039750B (zh) 2005-02-18
EE04657B1 (et) 2006-08-15
HUP0103454A3 (en) 2003-11-28
PT1112065E (pt) 2004-04-30
EP1112065A1 (en) 2001-07-04
SK3072001A3 (en) 2002-05-09
EP1112065B1 (en) 2003-12-17
JP4619537B2 (ja) 2011-01-26

Similar Documents

Publication Publication Date Title
YU19301A (sh) Farmaceutska kompozicija koja sadrži entakapon ili nitekapon kao i umreženi derivat celuloze
NO20041287L (no) Komprimerte, faste orale doseringformer av valsartan
BR9902086A (pt) Formulações farmacêuticas.
NO963673L (no) Orale vehikkelblandinger
JP2001509184A5 (tr)
JPH1072351A5 (tr)
DK1079811T3 (da) Biologisk nedbrydelige alginatgeler med forlænget frigivelse
BG103930A (en) Eletriptan hemisulphate and caffeine containing pharmaceutical compositions
CA2356380A1 (en) Immunosuppressive effects of pteridine derivatives
CA2209060A1 (en) Water-soluble or water-swellable polymers
JP2000503980A5 (tr)
IL143673A0 (en) Compositions comprising 1,1,1,3,3-pentaflurobutane and use of said compositions
AU3073599A (en) Novel powder compositions
DE69839696D1 (de) Anellierte dihydropyrane
BR9815747A (pt) Composição para liberação de aroma
BR9804027A (pt) Novos beta-ceto ésteres
CA2145248A1 (fr) Compositions pharmaceutiques permettant la liberation prolongee de trimetazidine apres administration par voie orale
SG162605A1 (en) Pharmaceutical compositions
AU1843397A (en) Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
BR9907655A (pt) Derivados de ácido di-hidróxi-hexanóico
AU2111999A (en) Compositions of 1,1,1,3,3-pentafluoropropane and chlorinated ethylenes
DK0921793T3 (da) Faste, ikke-henflydende formuleringer af natriumvalproat
EP0948521A4 (en) 19-NOR-CHOLANE STEROIDS AS NEUROCHEMICAL INITIATORS FOR CHANGING HUMAN HYPOTHALAMIC FUNCTION
AP9801306A0 (en) Contraceptive release system with an antibacterial action and/or antiviral action.
AU3896899A (en) Compositions for the treatment of tumors, and uses thereof